6月23日，健康160盘中上涨8.84%，报12.48港元/股，成交额1243.17万港元。
消息面上，近期多重利好共振：智谱GLM-5.2以MIT协议全量开源，支持本地化部署，解决公立医院数据合规与成本两大痛点，为健康160"160AI医院"规模化嵌入HIS系统提供基座红利；同时证监会明确将科创板第五套标准扩容至AI领域，重点支持未来健康与医疗智能体方向。公司层面，"160AI医院"累计签约公立医疗机构120家，三甲医院66家，据弗若斯特沙利文报告位居中国AI医院运营服务商行业第一，高毛利数字医疗板块持续驱动盈利改善。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.